SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates

SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates

<p>Abstract</p> <p>Background</p> <p>This study aimed to show that SHOX2 DNA methylation is a tumor marker in patients with suspected lung cancer by using bronchial fluid aspirated during bronchoscopy. Such a biomarker would be clinically valuable, especially when, foll...

Full description

Bibliographic Details
Main Authors: Liloglou Triantafillos, Wille Ulrike, Weickmann Sabine, Tetzner Reimo, Distler Jürgen, Lewin Jörn, Seemann Stefanie, Flemming Nadja, Seegebarth Anke, Schlegel Thomas, Kneip Christoph, Dietrich Dimo, Liebenberg Volker, Schmidt Bernd, Raji Olaide, Walshaw Martin, Fleischhacker Michael, Witt Christian, Field John K
Format: Article
Language:English
Published: BMC 2010-11-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/10/600

Internet

http://www.biomedcentral.com/1471-2407/10/600

Similar Items